What is Medtronic's EBITDA margin?

Latest reported EBITDA margin for Medtronic (MDT) is 25.01% as of the trailing twelve months (TTM) ending April 24, 2026.

How has Medtronic EBITDA margin changed year-over-year?

Medtronic (MDT) EBITDA margin changed −8.6 percentage points year-over-year on the latest annual filing.

When did Medtronic EBITDA margin hit its highest annual value?

Medtronic EBITDA margin reached its highest annual value of 48.30% in 1998.

What was Medtronic EBITDA margin in 2025?

Medtronic (MDT) EBITDA margin in 2025 was 27.49%.

What was Medtronic EBITDA margin in 2026?

Medtronic (MDT) EBITDA margin in 2026 was 18.84%.

Medtronic (MDT) EBITDA Margin — Annual & Quarterly %

TTM

25.0%

YoY change

−8.65pp

Trough year (2026)

18.8%

Peak year (1998)

48.3%

EBITDA Margin history chart for Medtronic (MDT) from 1986 to 2026

Latest: 18.8%

EBITDA Margin change chart for Medtronic (MDT) from 1986 to 2026

Latest: −8.65pp

EBITDA Margin history table for Medtronic (MDT) from 1986 to 2026


2026	18.8%	-8.65pp	Apr 24, 2026	Jun 3, 2026
2025	27.5%	+2.14pp	Apr 30, 2025	Jun 20, 2025
2024	25.3%	-2.50pp	Apr 30, 2024	Jun 20, 2024
2023	27.9%	+0.15pp	Apr 30, 2023	Jun 22, 2023
2022	27.7%	+2.72pp	Apr 30, 2022	Jun 23, 2022
2021	25.0%	-2.04pp	Apr 30, 2021	Jun 25, 2021
2020	27.0%	-3.42pp	Apr 30, 2020	Jun 19, 2020
2019	30.4%	-1.16pp	Apr 30, 2019	Jun 21, 2019
2018	31.6%	+2.61pp	Apr 30, 2018	Jun 22, 2018
2017	29.0%	-0.64pp	Apr 30, 2017	Jun 27, 2017
2016	29.6%	+2.69pp	Apr 30, 2016	Jun 28, 2016
2015	26.9%	-2.08pp	Apr 30, 2015	Jun 23, 2015
2014	29.0%	-3.88pp	Apr 30, 2014	Apr 30, 2014
2013	32.9%	-0.02pp	Apr 30, 2013	Apr 30, 2013
2012	32.9%	+2.05pp	Apr 30, 2012	Apr 30, 2012
2011	30.9%	-1.49pp	Apr 30, 2011	Apr 30, 2011
2010	32.4%	+8.31pp	Apr 30, 2010	Apr 30, 2010
2009	24.0%	-3.90pp	Apr 30, 2009	Apr 30, 2009
2008	27.9%	-7.19pp	Apr 30, 2008	Apr 30, 2008
2007	35.1%	-2.49pp	Apr 30, 2007	Apr 30, 2007
2006	37.6%	-1.23pp	Apr 30, 2006	Apr 30, 2006
2005	38.9%	-1.02pp	Apr 30, 2005	Apr 30, 2005
2004	39.9%	-0.06pp	Apr 30, 2004	Apr 30, 2004
2003	39.9%	+1.28pp	Apr 30, 2003	Apr 30, 2003
2002	38.7%	-0.52pp	Apr 30, 2002	Apr 30, 2002
2001	39.2%	+0.75pp	Apr 30, 2001	Apr 30, 2001
2000	38.4%	+0.23pp	Apr 30, 2000	Apr 30, 2000
1999	38.2%	-10.10pp	Apr 30, 1999	Apr 30, 1999
1998	48.3%	+5.43pp	Apr 30, 1998	Apr 30, 1998
1997	42.9%	+8.39pp	Apr 30, 1997	Apr 30, 1997
1996	34.5%	+3.33pp	Apr 30, 1996	Apr 30, 1996
1995	31.2%	+1.59pp	Apr 30, 1995	Apr 30, 1995
1994	29.6%	+2.11pp	Apr 30, 1994	Apr 30, 1994
1993	27.5%	+1.51pp	Apr 30, 1993	Apr 30, 1993
1992	25.9%	+1.19pp	Apr 30, 1992	Apr 30, 1992
1991	24.8%	+0.33pp	Apr 30, 1991	Apr 30, 1991
1990	24.4%	+0.93pp	Apr 30, 1990	Apr 30, 1990
1989	23.5%	-0.85pp	Apr 30, 1989	Apr 30, 1989
1988	24.4%	-1.96pp	Apr 30, 1988	Apr 30, 1988
1987	26.3%	+1.59pp	Apr 30, 1987	Apr 30, 1987
1986	24.7%	—	Apr 30, 1986	Apr 30, 1986

202618.8%-8.65pp
202527.5%+2.14pp
202425.3%-2.50pp
202327.9%+0.15pp
202227.7%+2.72pp
202125.0%-2.04pp
202027.0%-3.42pp
201930.4%-1.16pp
201831.6%+2.61pp
201729.0%-0.64pp
201629.6%+2.69pp
201526.9%-2.08pp
201429.0%-3.88pp
201332.9%-0.02pp
201232.9%+2.05pp
201130.9%-1.49pp
201032.4%+8.31pp
200924.0%-3.90pp
200827.9%-7.19pp
200735.1%-2.49pp
200637.6%-1.23pp
200538.9%-1.02pp
200439.9%-0.06pp
200339.9%+1.28pp
200238.7%-0.52pp
200139.2%+0.75pp
200038.4%+0.23pp
199938.2%-10.10pp
199848.3%+5.43pp
199742.9%+8.39pp
199634.5%+3.33pp
199531.2%+1.59pp
199429.6%+2.11pp
199327.5%+1.51pp
199225.9%+1.19pp
199124.8%+0.33pp
199024.4%+0.93pp
198923.5%-0.85pp
198824.4%-1.96pp
198726.3%+1.59pp
198624.7%—

EBITDA Margin values are taken from Medtronic's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Medtronic (MDT)

According to Medtronic's latest reported financial statements, the company's latest reported EBITDA margin is 25.0%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending April 24, 2026 (reported June 3, 2026). Chart and table below cover the full reported history back to 1986.

Medtronic (MDT) most recent annual EBITDA margin stands at 18.84% (2026) – contracted 8.6 percentage points year-over-year.

1998 marks the peak EBITDA margin at 48.30%, with the historical low of 18.84% recorded in 2026.

Medtronic EBITDA Margin by Year

Medtronic EBITDA Margin 2026: 18.8%

In 2026, Medtronic reported EBITDA margin of 18.84%, contracted 8.6 percentage points from 2025. This figure represents the lowest annual value in the available history.

Medtronic EBITDA Margin 2025: 27.5%

Medtronic EBITDA margin in 2025 was 27.49%, expanded 2.1 percentage points from 2024.

Medtronic EBITDA Margin 2024: 25.3%

2024's EBITDA margin for Medtronic came in at 25.35%, contracted 2.5 percentage points from 2023.

Medtronic EBITDA Margin 2023: 27.9%

Medtronic posted EBITDA margin of 27.85% in 2023, expanded 0.2 percentage points from 2022.

Medtronic EBITDA Margin 2022: 27.7%

Medtronic EBITDA margin in 2022 was 27.70%.

See more financial history for Medtronic (MDT).

Sector peers by EBITDA Margin

Healthcare peers of Medtronic (MDT), ranked by their latest EBITDA margin


Novo Nordisk (NVO)	55.4%
Amgen (AMGN)	46.6%
Eli Lilly (LLY)	45.9%
Merck & Co. (MRK)	34.6%
AstraZeneca (AZN)	33.9%
Johnson & Johnson (JNJ)	30.3%
AbbVie (ABBV)	26.9%
UnitedHealth Group (UNH)	5.1%

Frequently asked questions

Medtronic (MDT) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation